RMTI - Rockwell Medical, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5206.79M
Enterprise Value 3160.84M
Trailing P/E N/A
Forward P/E 1-9.26
PEG Ratio (5 yr expected) 1-0.18
Price/Sales (ttm)3.23
Price/Book (mrq)6.94
Enterprise Value/Revenue 32.52
Enterprise Value/EBITDA 6-4.96

Trading Information

Stock Price History

Beta (3Y Monthly) 1.30
52-Week Change 3-24.15%
S&P500 52-Week Change 32.59%
52 Week High 36.8800
52 Week Low 32.1900
50-Day Moving Average 32.6029
200-Day Moving Average 33.9860

Share Statistics

Avg Vol (3 month) 3408.81k
Avg Vol (10 day) 3264.73k
Shares Outstanding 563.82M
Float 58.45M
% Held by Insiders 119.62%
% Held by Institutions 138.12%
Shares Short (Aug 15, 2019) 46.78M
Short Ratio (Aug 15, 2019) 416.28
Short % of Float (Aug 15, 2019) 414.86%
Short % of Shares Outstanding (Aug 15, 2019) 410.63%
Shares Short (prior month Jul 15, 2019) 46.75M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin -52.11%
Operating Margin (ttm)-51.89%

Management Effectiveness

Return on Assets (ttm)-42.10%
Return on Equity (ttm)-143.35%

Income Statement

Revenue (ttm)63.93M
Revenue Per Share (ttm)1.14
Quarterly Revenue Growth (yoy)-0.50%
Gross Profit (ttm)-1.58M
EBITDA -32.42M
Net Income Avi to Common (ttm)-33.32M
Diluted EPS (ttm)-0.5950
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)35.23M
Total Cash Per Share (mrq)0.55
Total Debt (mrq)5.24M
Total Debt/Equity (mrq)17.69
Current Ratio (mrq)3.25
Book Value Per Share (mrq)0.47

Cash Flow Statement

Operating Cash Flow (ttm)-26.34M
Levered Free Cash Flow (ttm)-15M